ORMP
Oramed Pharmaceuticals, Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$3.43
+0.05 ▲ +1.48%
🌙 3월 13일 5:44 PM ET (한국 3/14 06:44)
$3.35
-0.08 ▼ -2.43%
| Index | - | P/E | 3.42 | EPS (ttm) | 1 | Insider Own | 22.95% | Shs Outstand | 0.04B | Perf Week | 4.41% |
| Market Cap | 0.14B | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | 0.03B | Perf Month | 5.54% |
| Enterprise Value | 0.00B | PEG | - | EPS next Q | - | Inst Own | 28.17% | Short Float | 1.81% | Perf Quarter | 26.87% |
| Income | 0.04B | P/S | 68.26 | EPS this Y | - | Inst Trans | 9.67% | Short Ratio | 2.54 | Perf Half Y | 51.41% |
| Sales | 0.00B | P/B | 0.69 | EPS next 5Y | - | ROA | 22.75% | Short Interest | 0.56M | Perf YTD | 29.1% |
| Book/sh | 4.98 | P/C | 1.01 | EPS past 3/5Y | 15.77% 10.71% | ROE | 24.38% | 52W High | -8.78% ($3.76) | Perf Year | 53.94% |
| Cash/sh | 3.38 | P/FCF | - | Sales past 3/5Y | - | ROIC | 21.51% | 52W Low | 102.16% ($1.70) | Perf 3Y | 83.05% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 814.2% | Gross Margin | -5.45% | Volatility(W/M) | 5.35% 6.07% | Perf 5Y | -60.86% |
| Dividend TTM | - | EV/Sales | 0.87 | Sales Y/Y TTM | 196.74% | Oper. Margin | -650.55% | ATR (14) | 0.2 | Perf 10Y | -44.25% |
| Dividend Ex-Date | 2026/1/16 | Quick Ratio | 22.24 | EPS Q/Q | 335.86% | Profit Margin | 2192.6% | RSI (14) | 53.09 | Recom | 3 |
| Dividend Gr. 3/5Y | - | Current Ratio | 22.24 | Sales Q/Q | - | SMA20 | 1.9% ($3.37) | Beta | 1.28 | Target Price | $6.25 |
| Payout | - | Debt/Eq | 0 | Earnings | 2026/02/25 | SMA50 | 3.45% ($3.32) | Rel Volume | 1.01 | Prev Close | $3.38 |
| Employees | 13 | LT Debt/Eq | 0 | EPS/Sales Surpr. | - | SMA200 | 38.27% ($2.48) | Avg Volume(3M) | 0.22M | Price | $3.43 |
| IPO | 2004/3/19 | Option/Short | Yes/Yes | Trades | 1736 | Volume | 221,755 | Change | 1.48% |
뉴스 로딩 중...